Combination Therapy of L19IL2 and Gemcitabine in Advanced Pancreatic Cancer Patients

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2014 by Philogen S.p.A.
Sponsor:
Information provided by (Responsible Party):
Philogen S.p.A.
ClinicalTrials.gov Identifier:
NCT01198522
First received: September 8, 2010
Last updated: February 24, 2014
Last verified: February 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2015
  Estimated Primary Completion Date: June 2015 (Final data collection date for primary outcome measure)